We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Chugai Pharmaceutical

News List

Thermo Fisher, Chugai Pharmaceutical Enter Companion Diagnostic Agreement americanpharmaceuticalreview
July 17, 2020
Thermo Fisher Scientific has signed a companion diagnostic (CDx) agreement with Chugai Pharmaceutical, a member of the Roche Group, and has applied to the Ministry of Health, Labour and Welfare (MHLW) to expand the use of the Oncomine Dx Target Test in...
Roche’s Hemlibra secures extended FDA approval for haemophilia A pharmaceutical-technology
October 09, 2018
Roche has secured approval from the US Food and Drug Administration (FDA) for the use of Hemlibra (emicizumab-kxwh) to treat haemophilia A patients without factor VIII inhibitors.
Chugai Pharmaceutical to expand Singaporean research subsidiary pharmaceutical-technology
July 30, 2018
Japan-based Chugai Pharmaceutical has revealed plans to expand its research subsidiary in Singapore, Chugai Pharmabody Research (CPR), in order to enhance its drug discovery capabilities.